COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz

In light of the persistent SARS-CoV‑2 pandemic and the current lack of treatment options, this work discusses therapeutic options using Chinese herbal medicines that have shown promise in initial observational studies. In addition, a therapeutic option for the increasing number of postinfectious sta...

Descripción completa

Detalles Bibliográficos
Autor principal: Thede, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574989/
http://dx.doi.org/10.1007/s42212-020-00316-x
_version_ 1783597729085128704
author Thede, Christian
author_facet Thede, Christian
author_sort Thede, Christian
collection PubMed
description In light of the persistent SARS-CoV‑2 pandemic and the current lack of treatment options, this work discusses therapeutic options using Chinese herbal medicines that have shown promise in initial observational studies. In addition, a therapeutic option for the increasing number of postinfectious states of weakness (fatigue symptoms) is presented, which in selected cases can be viewed as a “lesser yang syndrome” and treated with promise.
format Online
Article
Text
id pubmed-7574989
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-75749892020-10-21 COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz Thede, Christian Dtsch Z Akupunkt Review In light of the persistent SARS-CoV‑2 pandemic and the current lack of treatment options, this work discusses therapeutic options using Chinese herbal medicines that have shown promise in initial observational studies. In addition, a therapeutic option for the increasing number of postinfectious states of weakness (fatigue symptoms) is presented, which in selected cases can be viewed as a “lesser yang syndrome” and treated with promise. Springer Medizin 2020-10-20 2020 /pmc/articles/PMC7574989/ http://dx.doi.org/10.1007/s42212-020-00316-x Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Thede, Christian
COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz
title COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz
title_full COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz
title_fullStr COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz
title_full_unstemmed COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz
title_short COVID-19 – Therapiemöglichkeiten mit chinesischen Arzneimitteln in der Akutphase und Rekonvaleszenz
title_sort covid-19 – therapiemöglichkeiten mit chinesischen arzneimitteln in der akutphase und rekonvaleszenz
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574989/
http://dx.doi.org/10.1007/s42212-020-00316-x
work_keys_str_mv AT thedechristian covid19therapiemoglichkeitenmitchinesischenarzneimittelninderakutphaseundrekonvaleszenz

Ejemplares similares